Brachytherapy, also known as internal radiation therapy, is a form of cancer treatment where a radioactive source is placed inside or next to the area requiring treatment. It is commonly used to treat cancers of the cervix, prostate, breast, head and neck. By delivering radiation directly to the tumor site, brachytherapy provides an effective way to kill cancer cells without exposing nearby healthy tissues to as much radiation.
What is Brachytherapy?
Brachytherapy works by precisely placing radioactive sources inside or next to the cancerous tumor. These radioactive sources, also known as radioisotopes, emit high doses of radiation that kill the cancer cells while limiting exposure to surrounding healthy tissues. There are two main types of brachytherapy - low-dose rate (LDR) brachytherapy and high-dose rate (HDR) brachytherapy.
In LDR Brachytherapy also called seed implantation, small radioactive seeds are permanently placed inside or around the tumor site. These seeds have a low and continuous emission of radiation over weeks to months as they slowly dissolve. LDR brachytherapy is commonly used to treat prostate cancer.
In HDR brachytherapy, a higher dose of radioactive material is briefly placed in, on or near the tumor site using applicators such as hollow catheters or needles. The radioactive source is removed once the prescribed radiation dose is delivered, typically over minutes. HDR brachytherapy allows doctors to precisely target the radiation to the tumor shape while avoiding nearby organs. It is commonly used to treat cancers of the cervix, vagina, skin, and others.
Common Cancers Treated with Brachytherapy
Prostate Cancer
Brachytherapy is one of the standard treatment options for men with low-risk prostate cancer. The use of LDR radioactive seeds provides an effective radiation dose directly to the prostate gland. Brachytherapy for prostate cancer often offers fewer side effects than external beam radiation therapy. It allows men to return to regular activities more quickly.
Breast Cancer
For early-stage breast cancer, brachytherapy adds a radiation "boost" directly to the tumor site after lumpectomy surgery to remove the cancer. This focalized approach delivers high-dose radiation to the tumor area while minimizing exposure to nearby healthy breast tissue and tissues further away like the heart and lungs. It helps prevent cancer recurrence while preserving breast shape and size.
Cervical Cancer
HDR brachytherapy is commonly used along with external beam radiation and chemotherapy to treat cervical cancer. Short-term placement of radioactive sources directly in the cervix and nearby tissues using applicators provides an effective full radiation dose to the tumor region. This intensive localized treatment approach achieves high cure rates for cervical cancer.
Other Cancer Types
Brachytherapy is also used to treat head and neck cancers like oral, tongue, and laryngeal cancers. Catheter-based HDR brachytherapy delivers targeted radiation directly to these small and hard to reach tumor sites. Brachytherapy is also effective for skin, vaginal, esophageal, and some eye cancers. With advanced techniques, it precisely shapes radiation doses to irregularly shaped tumors.
Benefits of Brachytherapy
Along with effectively treating cancers, brachytherapy offers several benefits compared to external beam radiation therapy:
- Higher Radiation Dose: By placing radiation sources directly in or near tumors, brachytherapy allows delivery of a much higher radiation dose compared to external beam radiation therapy. This higher localized dose is more effective at killing cancer cells.
- Focalized Treatment: Radiation is concentrated on just the tumor site. Surrounding healthy tissues are exposed to much less radiation compared to whole area external beam treatments. This minimizes side effects.
- Shorter Treatment Time: Brachytherapy treatments are typically completed over a few minutes to a few days compared to weeks for external beam. This means less disruption to daily routines.
- Preserves Organ Function: The dose to nearby organs is kept low, thereby preserving organ function like urinary, sexual, and bowel function.
- Cost Effective: Brachytherapy treatments generally require fewer hospital visits compared to external beam radiation. This reduces both medical costs and time missed from work.
Latest Advancements
Technological advancements continue to improve brachytherapy treatment. 3D imaging and planning software now allows unprecedented accuracy in delivering conformal radiation doses to irregular tumor shapes. High-activity radioactive sources and afterloader technology are used to optimize HDR brachytherapy treatment delivery. Newer precise techniques like stereotactic body radiation therapy enable brachytherapy for tumors previously considered inoperable. Taken together, these modern advancements have expanded the scope of cancers brachytherapy can effectively treat while minimizing side effects.
In summary, brachytherapy is a powerful form of cancer treatment that precisely delivers high radiation doses directly to tumors. Its focalized approach treats cancer more effectively compared to whole area external beam radiation therapy, while limiting dose to surrounding healthy tissues. Combined with other treatments, brachytherapy offers cure rates on par with surgery for several localized cancers. Technological advances now enable its use across an even wider range of tumor sites. For selected patients, brachytherapy continues to emerge as a highly effective treatment option.
For more insights, read- https://www.insightprobing.com/brachytherapy-trends-size-and-share-analysis/
For more details on the report, Read- https://techaxen.com/conducting-connections-exploring-the-vital-role-of-thermal-interface-materials-in-heat-dissipation-in-electronics/
The global stereotactic surgery devices market size is expected to reach USD 25.9 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.9% during the forecast period.
Stereotactic surgery is a minimally invasive alternative for traditional invasive ablation and biopsy methods.
Since, stereotactic surgery has various advantages such as higher efficacy, minimal or no surgical incisions, and lower risk of damage to healthy cells, it is replacing conventional radiotherapies.
These surgical procedures have helped overcome drawbacks associated with traditional invasive surgeries, such as destruction of healthy cells and higher risk of recurrence & postoperative complications.Only around 10.0% of the population in low and middle-income countries have access to radiation therapy, owing to dearth of radiation therapy devices.
A market leader, Elekta, in its 2016 annual report stated that the number of installations of linear accelerators in high-income countries was approximately 13,000, whereas the requirement was around 25,000.
Hence, huge demand-supply discrepancy of radiotherapy devices is likely to open new avenues for major market players in developing countries.Request a Sample Copy of the Global Stereotactic Surgery Devices Market Research Report @ www.grandviewresearch.com/industry-analysis/stereotactic-surgery-devices-market/request/rs1Further key findings from the study suggest:Linear accelerators (LINAC) accounted for the leading volume share in 2017, owing to higher affordability and larger commercial availabilityCyberKnife is poised to exhibit the fastest growth over the forecast period owing to their growing adoption in developing countriesNorth America dominated the market in 2017 due to number of government initiatives focused on creating awareness regarding availability of advanced treatment options and presence of developed healthcare infrastructureSome of the major players operating in the market are Siemens Ag, Elekta AB, Varian Medical Systems, IBA, and Accuray IncorporatedThese players dominate the market with their strong brand identity and extensive geographical reach attained through various strategic initiatives such as mergers & acquisitions and partnership agreements.Access full research report on global stereotactic surgery devices market: www.grandviewresearch.com/industry-analysis/stereotactic-surgery-devices-market
Why You Require Mailing Lists
Targeted Radiation oncologists mailing lists could help you get connected with the best experts across the globe.
They work with radiation therapists and Radiation Oncology medical physicists to assess individual patients, determine the best management plan, and determine recovery progress.
Cancer is a leading cause of death worldwide and accounts for 8.2 million deaths and this number has been predicted to increase to 13 million by 2030.
Medicoleads’ Radiation Oncology Email List is the norm when it comes to achieving high quality leads as it contains data driven, verified contacts of over 6,000 Radiation Oncology Physicians.
Targeted Campaigns with our Radiation Oncologist Mailing List
